MedTrace Logo

Observational Trial With Leios/Alesse

NCT00481650 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2007-12-10

No results posted yet for this study

Summary

A prospective, observational study (Anwendungsbeobachtung \[AWB\]) of the prescribing and administration practices of German gynecologists with Leios® Dragées.

Conditions

  • Contraceptives, Oral, Combined

Interventions

DRUG

Leios/Alesse

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer

  • Trial Manager · For Germany, [email protected]

Eligibility

Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-05-31
Completion
2007-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00481650 on ClinicalTrials.gov